Revance Therapeutics Statistics
Total Valuation
VERB has a market cap or net worth of $13.48 million. The enterprise value is $2.45 million.
Important Dates
The next estimated earnings date is Wednesday, August 13, 2025, after market close.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VERB has 1.42 million shares outstanding. The number of shares has increased by 1,081.10% in one year.
| Current Share Class | 1.42M |
| Shares Outstanding | 1.42M |
| Shares Change (YoY) | +1,081.10% |
| Shares Change (QoQ) | +5.66% |
| Owned by Insiders (%) | 0.10% |
| Owned by Institutions (%) | 1.98% |
| Float | 1.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.51 |
| Forward PS | 2.13 |
| PB Ratio | 0.73 |
| P/TBV Ratio | 1.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.91, with a Debt / Equity ratio of 0.02.
| Current Ratio | 3.91 |
| Quick Ratio | 3.60 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -852.77 |
Financial Efficiency
Return on equity (ROE) is -66.59% and return on invested capital (ROIC) is -45.87%.
| Return on Equity (ROE) | -66.59% |
| Return on Assets (ROA) | -35.72% |
| Return on Invested Capital (ROIC) | -45.87% |
| Return on Capital Employed (ROCE) | -75.29% |
| Revenue Per Employee | $115,421 |
| Profits Per Employee | -$553,474 |
| Employee Count | 19 |
| Asset Turnover | 0.11 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.26% in the last 52 weeks. The beta is 0.86, so VERB's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -48.26% |
| 50-Day Moving Average | 7.96 |
| 200-Day Moving Average | 6.98 |
| Relative Strength Index (RSI) | 56.71 |
| Average Volume (20 Days) | 39,735 |
Short Selling Information
The latest short interest is 42,385, so 2.99% of the outstanding shares have been sold short.
| Short Interest | 42,385 |
| Short Previous Month | 58,150 |
| Short % of Shares Out | 2.99% |
| Short % of Float | 2.99% |
| Short Ratio (days to cover) | 1.97 |
Income Statement
In the last 12 months, VERB had revenue of $2.19 million and -$10.52 million in losses. Loss per share was -$13.01.
| Revenue | 2.19M |
| Gross Profit | 1.63M |
| Operating Income | -11.09M |
| Pretax Income | n/a |
| Net Income | -10.52M |
| EBITDA | -10.98M |
| EBIT | -11.09M |
| Loss Per Share | -$13.01 |
Full Income StatementBalance Sheet
The company has $11.36 million in cash and $317,000 in debt, giving a net cash position of $11.04 million or $7.79 per share.
| Cash & Cash Equivalents | 11.36M |
| Total Debt | 317,000 |
| Net Cash | 11.04M |
| Net Cash Per Share | $7.79 |
| Equity (Book Value) | 14.54M |
| Book Value Per Share | 13.11 |
| Working Capital | 10.61M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.63 million and capital expenditures -$385,000, giving a free cash flow of -$8.01 million.
| Operating Cash Flow | -7.63M |
| Capital Expenditures | -385,000 |
| Free Cash Flow | -8.01M |
| FCF Per Share | -$5.65 |
Full Cash Flow StatementMargins
| Gross Margin | 74.19% |
| Operating Margin | -505.52% |
| Pretax Margin | -433.33% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VERB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1,081.10% |
| Shareholder Yield | -1,081.10% |
| Earnings Yield | -77.98% |
| FCF Yield | -59.41% |
Analyst Forecast
The average price target for VERB is $62.00, which is 551.95% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $62.00 |
| Price Target Difference | 551.95% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 9, 2024. It was a reverse split with a ratio of 1:200.
| Last Split Date | Oct 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:200 |
Scores
VERB has an Altman Z-Score of -14.14 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.14 |
| Piotroski F-Score | 4 |
